Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946218 · ClinicalTrials.gov registry record
Diagnosis and Characterization of Dengue Fever in Children
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 258
- Enrollment target
NCT00946218: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT00946218 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 258 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946218 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 258 participants
- Enrollment target
Study Summary
Dengue virus is an arbovirus transmitted by mosquitoes which causes significant morbidity and mortality among children in tropical regions, especially in resource limited countries. The objective of this protocol is to compare the sensitivity and specificity of clinical gestalt and two rapid antigen tests for dengue virus and to compare the gene expression of leukocytes in distinct dengue fever disease phenotypes module-based RNA microarray technology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
What the finished NCT00946218 record still lists
NCT00946218 is an observational study that tracks outcomes without assigning an intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00946218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00946218 about?
NCT00946218 is a clinical study titled "Diagnosis and Characterization of Dengue Fever in Children". Dengue virus is an arbovirus transmitted by mosquitoes which causes significant morbidity and mortality among children in tropical regions, especially in resource limited countries. The objective of this protocol is to compare the sensitivity and specificity of clinical gestalt and two rapid antigen...
What is the current status of trial NCT00946218?
This trial is currently completed. The enrollment target is 258 participants. The study started on 2009-07. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00946218?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia